Truist Securities Reiterates Buy on Eli Lilly, Maintains $650 Price Target

Eli Lilly and Company -0.15%

Eli Lilly and Company

LLY

770.00

-0.15%

Truist Securities analyst Robyn Karnauskas reiterates Eli Lilly (NYSE: LLY) with a Buy and maintains $650 price target.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via